rdf:type |
|
lifeskim:mentions |
umls-concept:C0007222,
umls-concept:C0022661,
umls-concept:C0027051,
umls-concept:C0035647,
umls-concept:C0038952,
umls-concept:C0403447,
umls-concept:C0871261,
umls-concept:C1524081,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2675972,
umls-concept:C2911692
|
pubmed:issue |
24
|
pubmed:dateCreated |
2004-12-14
|
pubmed:abstractText |
Persons with end-stage renal disease and those with lesser degrees of chronic kidney disease (CKD) have an increased risk of death after myocardial infarction (MI) that is not fully explained by associated comorbidities. Future cardiovascular event rates and the relative response to therapy in persons with mild to moderate CKD are not well characterized.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3667-73
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15569840-Aged,
pubmed-meshheading:15569840-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:15569840-Captopril,
pubmed-meshheading:15569840-Chronic Disease,
pubmed-meshheading:15569840-Female,
pubmed-meshheading:15569840-Glomerular Filtration Rate,
pubmed-meshheading:15569840-Humans,
pubmed-meshheading:15569840-Kidney Diseases,
pubmed-meshheading:15569840-Kidney Failure, Chronic,
pubmed-meshheading:15569840-Male,
pubmed-meshheading:15569840-Middle Aged,
pubmed-meshheading:15569840-Myocardial Infarction,
pubmed-meshheading:15569840-Proportional Hazards Models,
pubmed-meshheading:15569840-Randomized Controlled Trials as Topic,
pubmed-meshheading:15569840-Recurrence,
pubmed-meshheading:15569840-Risk
|
pubmed:year |
2004
|
pubmed:articleTitle |
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
|
pubmed:affiliation |
Department of Cardiology, St. George Hospital, Medical University Plovdiv, Plovdiv, Bulgaria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|